Authors

Edwin CK Tan

BPharm (Hons), PhD, NHMRC-ARC Dementia Research Development Fellow, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Vic; Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden. edwin.tan@monash.edu

Current approaches to the pharmacological treatment of Alzheimer’s disease

Medications may be used in conjunction with non-pharmacological treatments to manage cognition, function and behaviour in people with Alzheimer’s disease.